- •Contents
- •Contributors
- •Part I General Principles of Cell Death
- •1 Human Caspases – Apoptosis and Inflammation Signaling Proteases
- •1.1. Apoptosis and limited proteolysis
- •1.2. Caspase evolution
- •2. ACTIVATION MECHANISMS
- •2.2. The activation platforms
- •2.4. Proteolytic maturation
- •3. CASPASE SUBSTRATES
- •4. REGULATION BY NATURAL INHIBITORS
- •REFERENCES
- •2 Inhibitor of Apoptosis Proteins
- •2. CELLULAR FUNCTIONS AND PHENOTYPES OF IAP
- •3. IN VIVO FUNCTIONS OF IAP FAMILY PROTEINS
- •4. SUBCELLULAR LOCATIONS OF IAP
- •8. IAP–IAP INTERACTIONS
- •10. ENDOGENOUS ANTAGONISTS OF IAP
- •11. IAPs AND DISEASE
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2.1. The CD95 (Fas/APO-1) system
- •2.1.1. CD95 and CD95L: discovery of the first direct apoptosis-inducing receptor-ligand system
- •2.1.2. Biochemistry of CD95 apoptosis signaling
- •2.2. The TRAIL (Apo2L) system
- •3.1. The TNF system
- •3.1.1. Biochemistry of TNF signal transduction
- •3.1.2. TNF and TNF blockers in the clinic
- •3.2. The DR3 system
- •4. THE DR6 SYSTEM
- •6. CONCLUDING REMARKS AND OUTLOOK
- •SUGGESTED READINGS
- •4 Mitochondria and Cell Death
- •1. INTRODUCTION
- •2. MITOCHONDRIAL PHYSIOLOGY
- •3. THE MITOCHONDRIAL PATHWAY OF APOPTOSIS
- •9. CONCLUSIONS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •3. INHIBITING APOPTOSIS
- •4. INHIBITING THE INHIBITORS
- •6. THE BCL-2 FAMILY AND CANCER
- •SUGGESTED READINGS
- •6 Endoplasmic Reticulum Stress Response in Cell Death and Cell Survival
- •1. INTRODUCTION
- •2. THE ESR IN YEAST
- •3. THE ESR IN MAMMALS
- •4. THE ESR AND CELL DEATH
- •5. THE ESR IN DEVELOPMENT AND TISSUE HOMEOSTASIS
- •6. THE ESR IN HUMAN DISEASE
- •7. CONCLUSION
- •7 Autophagy – The Liaison between the Lysosomal System and Cell Death
- •1. INTRODUCTION
- •2. AUTOPHAGY
- •2.2. Physiologic functions of autophagy
- •2.3. Autophagy and human pathology
- •3. AUTOPHAGY AND CELL DEATH
- •3.1. Autophagy as anti–cell death mechanism
- •3.2. Autophagy as a cell death mechanism
- •3.3. Molecular players of the autophagy–cell death cross-talk
- •4. AUTOPHAGY, CELLULAR DEATH, AND CANCER
- •5. CONCLUDING REMARKS AND PENDING QUESTIONS
- •SUGGESTED READINGS
- •8 Cell Death in Response to Genotoxic Stress and DNA Damage
- •1. TYPES OF DNA DAMAGE AND REPAIR SYSTEMS
- •2. DNA DAMAGE RESPONSE
- •2.2. Transducers
- •2.3. Effectors
- •4. CHROMATIN MODIFICATIONS
- •5. CELL CYCLE CHECKPOINT REGULATION
- •6. WHEN REPAIR FAILS: SENESCENCE VERSUS APOPTOSIS
- •6.1. DNA damage response and the induction of apoptosis
- •6.2. p53-independent mechanisms of apoptosis
- •6.3. DNA damage response and senescence induction
- •7. DNA DAMAGE FROM OXIDATIVE STRESS
- •SUGGESTED READINGS
- •9 Ceramide and Lipid Mediators in Apoptosis
- •1. INTRODUCTION
- •3.1. Basic cell signaling often involves small molecules
- •3.2. Sphingolipids are cell-signaling molecules
- •3.2.1. Ceramide induces apoptosis
- •3.2.2. Ceramide accumulates during programmed cell death
- •3.2.3. Inhibition of ceramide production alters cell death signaling
- •4.1. Ceramide is generated through SM hydrolysis
- •4.3. aSMase can be activated independently of extracellular receptors to regulate apoptosis
- •4.4. Controversial aspects of the role of aSMase in apoptosis
- •4.5. De novo ceramide synthesis regulates programmed cell death
- •4.6. p53 and Bcl-2–like proteins are connected to de novo ceramide synthesis
- •4.7. The role and regulation of de novo synthesis in ceramide-mediated cell death is poorly understood
- •5. CONCLUDING REMARKS AND FUTURE DIRECTIONS
- •5.1. Who? (Which enzyme?)
- •5.2. What? (Which ceramide?)
- •5.3. Where? (Which compartment?)
- •5.4. When? (At what steps?)
- •5.5. How? (Through what mechanisms?)
- •5.6. What purpose?
- •6. SUMMARY
- •SUGGESTED READINGS
- •1. General Introduction
- •1.1. Cytotoxic lymphocytes and apoptosis
- •2. CYTOTOXIC GRANULES AND GRANULE EXOCYTOSIS
- •2.1. Synthesis and loading of the cytotoxic granule proteins into the secretory granules
- •2.2. The immunological synapse
- •2.3. Secretion of granule proteins
- •2.4. Uptake of proapoptotic proteins into the target cell
- •2.5. Activation of death pathways by granzymes
- •3. GRANULE-BOUND CYTOTOXIC PROTEINS
- •3.1. Perforin
- •3.2. Granulysin
- •3.3. Granzymes
- •3.3.1. GrB-mediated apoptosis
- •3.3.2. GrA-mediated cell death
- •3.3.3. Orphan granzyme-mediated cell death
- •5. CONCLUSIONS
- •REFERENCES
- •Part II Cell Death in Tissues and Organs
- •1.1. Death by trophic factor deprivation
- •1.2. Key molecules regulating neuronal apoptosis during development
- •1.2.1. Roles of caspases and Apaf-1 in neuronal cell death
- •1.2.2. Role of Bcl-2 family members in neuronal cell death
- •1.3. Signal transduction from neurotrophins and neurotrophin receptors
- •1.3.1. Signals for survival
- •1.3.2. Signals for death
- •2.1. Apoptosis in neurodegenerative diseases
- •2.1.4. Amyotrophic lateral sclerosis
- •2.2. Necrotic cell death in neurodegenerative diseases
- •2.2.1. Calpains
- •2.2.2. Cathepsins
- •3. CONCLUSIONS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •ACKNOWLEDGMENT
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •5. S-NITROSYLATION OF PARKIN
- •7. POTENTIAL TREATMENT OF EXCESSIVE NMDA-INDUCED Ca2+ INFLUX AND FREE RADICAL GENERATION
- •8. FUTURE THERAPEUTICS: NITROMEMANTINES
- •9. CONCLUSIONS
- •Acknowledgments
- •SUGGESTED READINGS
- •3. MITOCHONDRIAL PERMEABILITY TRANSITION ACTIVATED BY Ca2+ AND OXIDATIVE STRESS
- •4.1. Mitochondrial apoptotic pathways
- •4.2. Bcl-2 family proteins
- •4.3. Caspase-dependent apoptosis
- •4.4. Caspase-independent apoptosis
- •4.5. Calpains in ischemic neural cell death
- •5. SUMMARY
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. HISTORICAL ANTECEDENTS
- •7.1. Activation of p21 waf1/cip1: Targeting extrinsic and intrinsic pathways to death
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •16 Apoptosis and Homeostasis in the Eye
- •1.1. Lens
- •1.2. Retina
- •2. ROLE OF APOPTOSIS IN DISEASES OF THE EYE
- •2.1. Glaucoma
- •2.2. Age-related macular degeneration
- •4. APOPTOSIS AND OCULAR IMMUNE PRIVILEGE
- •5. CONCLUSIONS
- •SUGGESTED READINGS
- •17 Cell Death in the Inner Ear
- •3. THE COCHLEA IS THE HEARING ORGAN
- •3.1. Ototoxic hair cell death
- •3.2. Aminoglycoside-induced hair cell death
- •3.3. Cisplatin-induced hair cell death
- •3.4. Therapeutic strategies to prevent hair cell death
- •3.5. Challenges to studies of hair cell death
- •4. SPIRAL GANGLION NEURON DEATH
- •4.1. Neurotrophic support from sensory hair cells and supporting cells
- •4.2. Afferent activity from hair cells
- •4.3. Molecular manifestations of spiral ganglion neuron death
- •4.4. Therapeutic interventions to prevent SGN death
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •18 Cell Death in the Olfactory System
- •1. Introduction
- •2. Anatomical Aspects
- •3. Life and Death in the Olfactory System
- •3.1. Olfactory epithelium
- •3.2. Olfactory bulb
- •REFERENCES
- •1. Introduction
- •3.1. Beta cell death in the development of T1D
- •3.2. Mechanisms of beta cell death in type 1 diabetes
- •3.2.1. Apoptosis signaling pathways downstream of death receptors and inflammatory cytokines
- •3.2.2. Oxidative stress
- •3.3. Mechanisms of beta cell death in type 2 diabetes
- •3.3.1. Glucolipitoxicity
- •3.3.2. Endoplasmic reticulum stress
- •5. SUMMARY
- •Acknowledgments
- •REFERENCES
- •20 Apoptosis in the Physiology and Diseases of the Respiratory Tract
- •1. APOPTOSIS IN LUNG DEVELOPMENT
- •2. APOPTOSIS IN LUNG PATHOPHYSIOLOGY
- •2.1. Apoptosis in pulmonary inflammation
- •2.2. Apoptosis in acute lung injury
- •2.3. Apoptosis in chronic obstructive pulmonary disease
- •2.4. Apoptosis in interstitial lung diseases
- •2.5. Apoptosis in pulmonary arterial hypertension
- •2.6. Apoptosis in lung cancer
- •SUGGESTED READINGS
- •21 Regulation of Cell Death in the Gastrointestinal Tract
- •1. INTRODUCTION
- •2. ESOPHAGUS
- •3. STOMACH
- •4. SMALL AND LARGE INTESTINE
- •5. LIVER
- •6. PANCREAS
- •7. SUMMARY AND CONCLUDING REMARKS
- •SUGGESTED READINGS
- •22 Apoptosis in the Kidney
- •1. NORMAL KIDNEY STRUCTURE AND FUNCTION
- •3. APOPTOSIS IN ADULT KIDNEY DISEASE
- •4. REGULATION OF APOPTOSIS IN KIDNEY CELLS
- •4.1. Survival factors
- •4.2. Lethal factors
- •4.2.1. TNF superfamily cytokines
- •4.2.2. Other cytokines
- •4.2.3. Glucose
- •4.2.4. Drugs and xenobiotics
- •4.2.5. Ischemia-reperfusion and sepsis
- •5. THERAPEUTIC APPROACHES
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. APOPTOSIS IN THE NORMAL BREAST
- •2.1. Occurrence and role of apoptosis in the developing breast
- •2.2.2. Death ligands and death receptor pathway
- •2.2.4. LIF-STAT3 proapoptotic signaling
- •2.2.5. IGF survival signaling
- •2.2.6. Regulation by adhesion
- •2.2.7. PI3K/AKT pathway: molecular hub for survival signals
- •2.2.8. Downstream regulators of apoptosis: the BCL-2 family members
- •3. APOPTOSIS IN BREAST CANCER
- •3.1. Apoptosis in breast tumorigenesis and cancer progression
- •3.2. Molecular dysregulation of apoptosis in breast cancer
- •3.2.1. Altered expression of death ligands and their receptors in breast cancer
- •3.2.2. Deregulation of prosurvival growth factors and their receptors
- •3.2.3. Alterations in cell adhesion and resistance to anoikis
- •3.2.4. Enhanced activation of the PI3K/AKT pathway in breast cancer
- •3.2.5. p53 inactivation in breast cancer
- •3.2.6. Altered expression of BCL-2 family of proteins in breast cancer
- •5. CONCLUSION
- •SUGGESTED READINGS
- •1. INTRODUCTION
- •2. DETECTING CELL DEATH IN THE FEMALE GONADS
- •4. APOPTOSIS AND FEMALE REPRODUCTIVE AGING
- •6. CONCLUDING REMARKS
- •REFERENCES
- •25 Apoptotic Signaling in Male Germ Cells
- •1. INTRODUCTION
- •3.1. Murine models
- •3.2. Primate models
- •3.3. Pathways of caspase activation and apoptosis
- •3.4. Apoptotic signaling in male germ cells
- •5. P38 MITOGEN-ACTIVATED PROTEIN KINASE (MAPK) AND NITRIC OXIDE (NO)–MEDIATED INTRINSIC PATHWAY SIGNALING CONSTITUTES A CRITICAL COMPONENT OF APOPTOTIC SIGNALING IN MALE GERM CELLS AFTER HORMONE DEPRIVATION
- •11. CONCLUSIONS AND PERSPECTIVES
- •REFERENCES
- •26 Cell Death in the Cardiovascular System
- •1. INTRODUCTION
- •2. CELL DEATH IN THE VASCULATURE
- •2.1. Apoptosis in the developing blood vessels
- •2.2. Apoptosis in atherosclerosis
- •2.2.1. Vascular smooth muscle cells
- •2.2.2. Macrophages
- •2.2.3. Regulation of apoptosis in atherosclerosis
- •2.2.4. Necrosis and autophagy in atherosclerosis
- •3. CELL DEATH IN THE MYOCARDIUM
- •3.1. Cell death in myocardial infarction
- •3.1.1. Apoptosis in myocardial infarction
- •3.1.2. Necrosis in myocardial infarction
- •3.1.3. Autophagy in myocardial infarction
- •3.2. Cell death in heart failure
- •3.2.1. Apoptosis in heart failure
- •3.2.2. Necrosis in heart failure
- •3.2.3. Autophagy in heart failure
- •4. CONCLUDING REMARKS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •27 Cell Death Regulation in Muscle
- •1. INTRODUCTION TO MUSCLE
- •1.1. Skeletal muscle adaptation to endurance training
- •1.2. Myonuclear domains
- •2. MITOCHONDRIALLY MEDIATED APOPTOSIS IN MUSCLE
- •2.1. Skeletal muscle apoptotic susceptibility
- •4. APOPTOSIS IN MUSCLE DURING AGING AND DISEASE
- •4.1. Aging
- •4.2. Type 2 diabetes mellitus
- •4.3. Cancer cachexia
- •4.4. Chronic heart failure
- •6. CONCLUSION
- •SUGGESTED READINGS
- •28 Cell Death in the Skin
- •1. INTRODUCTION
- •2. CELL DEATH IN SKIN HOMEOSTASIS
- •2.1. Cornification and apoptosis
- •2.2. Death receptors in the skin
- •3. CELL DEATH IN SKIN PATHOLOGY
- •3.1. Sunburn
- •3.2. Skin cancer
- •3.3. Necrolysis
- •3.4. Pemphigus
- •3.5. Eczema
- •3.6. Graft-versus-host disease
- •4. CONCLUDING REMARKS AND PERSPECTIVES
- •ACKNOWLEDGMENTS
- •SUGGESTED READINGS
- •29 Apoptosis and Cell Survival in the Immune System
- •2.1. Survival of early hematopoietic progenitors
- •2.2. Sizing of the T-cell population
- •2.2.1. Establishing central tolerance
- •2.2.2. Peripheral tolerance
- •2.2.3. Memory T cells
- •2.3. Control of apoptosis in B-cell development
- •2.3.1. Early B-cell development
- •2.3.2. Deletion of autoreactive B cells
- •2.3.3. Survival and death of activated B cells
- •3. IMPAIRED APOPTOSIS AND LEUKEMOGENESIS
- •4. CONCLUSIONS
- •ACKNOWLEDGMENTS
- •REFERENCES
- •30 Cell Death Regulation in the Hematopoietic System
- •1. INTRODUCTION
- •2. HEMATOPOIETIC STEM CELLS
- •4. ERYTHROPOIESIS
- •5. MEGAKARYOPOIESIS
- •6. GRANULOPOIESIS
- •7. MONOPOIESIS
- •8. CONCLUSION
- •ACKNOWLEDGMENTS
- •REFERENCES
- •31 Apoptotic Cell Death in Sepsis
- •1. INTRODUCTION
- •2. HOST INFLAMMATORY RESPONSE TO SEPSIS
- •3. CLINICAL OBSERVATIONS OF CELL DEATH IN SEPSIS
- •3.1. Sepsis-induced apoptosis
- •3.2. Necrotic cell death in sepsis
- •4.1. Central role of apoptosis in sepsis mortality: immune effector cells and gut epithelium
- •4.2. Apoptotic pathways in sepsis-induced immune cell death
- •4.3. Investigations implicating the extrinsic apoptotic pathway in sepsis
- •4.4. Investigations implicating the intrinsic apoptotic pathway in sepsis
- •5. THE EFFECT OF APOPTOSIS ON THE IMMUNE SYSTEM
- •5.1. Cellular effects of an increased apoptotic burdens
- •5.2. Network effects of selective loss of immune cell types
- •5.3. Studies of immunomodulation by apoptotic cells in other fields
- •7. CONCLUSION
- •REFERENCES
- •32 Host–Pathogen Interactions
- •1. INTRODUCTION
- •2. FROM THE PATHOGEN PERSPECTIVE
- •2.1. Commensals versus pathogens
- •2.2. Pathogen strategies to infect the host
- •3. HOST DEFENSE
- •3.1. Antimicrobial peptides
- •3.2. PRRs and inflammation
- •3.2.1. TLRs
- •3.2.2. NLRs
- •3.2.3. The Nod signalosome
- •3.2.4. The inflammasome
- •3.3. Cell death
- •3.3.1. Apoptosis and pathogen clearance
- •3.3.2. Pyroptosis
- •3.2.3. Caspase-independent cell death
- •3.2.4. Autophagy and autophagic cell death
- •4. CONCLUSIONS
- •REFERENCES
- •Part III Cell Death in Nonmammalian Organisms
- •1. PHENOTYPE AND ASSAYS OF YEAST APOPTOSIS
- •2.1. Pheromone-induced cell death
- •2.1.1. Colony growth
- •2.1.2. Killer-induced cell death
- •3. EXTERNAL STIMULI THAT INDUCE APOPTOSIS IN YEAST
- •4. THE GENETICS OF YEAST APOPTOSIS
- •5. PROGRAMMED AND ALTRUISTIC AGING
- •SUGGESTED READINGS
- •34 Caenorhabditis elegans and Apoptosis
- •1. Overview
- •2. KILLING
- •3. SPECIFICATION
- •4. EXECUTION
- •4.1. DNA degradation
- •4.2. Mitochondrial elimination
- •4.3. Engulfment
- •5. SUMMARY
- •SUGGESTED READINGS
- •35 Apoptotic Cell Death in Drosophila
- •2. DROSOPHILA CASPASES AND PROXIMAL REGULATORS
- •6. CLOSING COMMENTS
- •SUGGESTED READINGS
- •36 Analysis of Cell Death in Zebrafish
- •1. INTRODUCTION
- •2. WHY USE ZEBRAFISH TO STUDY CELL DEATH?
- •2.2. Molecular techniques to rapidly assess gene function in embryos
- •2.2.1. Studies of gene function using microinjections into early embryos
- •2.2.2. In situ hybridization and immunohistochemistry
- •2.3. Forward genetic screening
- •2.4. Drug and small-molecule screening
- •2.5. Transgenesis
- •2.6. Targeted knockouts
- •3.1. Intrinsic apoptosis
- •3.2. Extrinsic apoptosis
- •3.3. Chk-1 suppressed apoptosis
- •3.4. Anoikis
- •3.5. Autophagy
- •3.6. Necrosis
- •4. DEVELOPMENTAL CELL DEATH IN ZEBRAFISH EMBRYOS
- •5. THE P53 PATHWAY
- •6. PERSPECTIVES AND FUTURE DIRECTIONS
- •SUGGESTED READING
APOPTOSIS AND CELL SURVIVAL IN THE IMMUNE SYSTEM |
341 |
particularly obvious in Faslpr/lprBim-/- mice. It is thus not a big surprise that natural selection would call on both apoptotic pathways (and also other tricks such as anergy and negative regulation) to prevent a fatal outcome.
2.2.3. Memory T cells
At the end of an immune response, the majority of effector T cells die by apoptosis, leaving behind a longlived population of memory T cells. Upon re-infection by the same pathogen, these cells proliferate strongly and undergo a rapid transition into effector cells.117,118 Memory T cells have long been considered to be generated from the pool of effector T cells that have responded to foreign antigens, and there is indeed evidence that some memory T cells have previously displayed effector functions.119 But memory T cells display many characteristics that are typical of na¨ıve cells, and this has led to the hypothesis that they may be generated directly from naive T cells without going through the effector state.120 The importance of cytokines, in particular of IL-7 and IL-15, in the maintenance and homeostasis of memory T cells is well recognized.118 Expression of IL-7Rα on T cells at the peak of the effector response to acute infection has been first correlated with the ability to survive the downsizing of immune response and progress to memory,121 but recent reports indicate that IL-7 signal is not sufficient for this process.122,123,124 IL-2 and some inflammatory signals such as IL-12 or type I interferons play an important role in the differentiation of memory
cells.125,126,127
The relative role of death receptor and mitochondrial pathways downstream of these cytokines in the maintenance of memory T cells is not clearly defined yet. The balance between Bim and Bcl-2 has been described as critical for the homeostasis of the memory T-cell population,19 and accumulation of memory T cells has also been observed in Bak/Bax-deficient mice.68 Interestingly, memory T-cell numbers were largely increased in mice lacking both Fas and Bim compared with mice lacking either of them alone,113 suggesting that here again, cooperation between both pathways may regulate the homeostasis of this cell population.
2.3. Control of apoptosis in B-cell development
2.3.1. Early B-cell development
The development of B cells resembles that of T cells in many aspects. The purpose of B-cell maturation is to produce a membrane BCR that can recognize foreign
antigens and ignore self-antigens.128 As is the case for TCR, production of a functional BCR first entails the rearrangement of genes encoding the different subunits of the pre-BCR, composed of the immunoglobulin heavy chain (Ig HC) with the λ5 and Vpre-B surrogate light chains. This happens at the pro-B cell stage, and successful assembly of the pre-BCR allows cells to survive and progress to the pre-B cell stages, during which immunoglobulin light chain (Ig LC) gene is rearranged and combined with Ig HC to form a functional BCR. As for the TCR components, rearrangement of BCR HC and LC is ensured by the recombination activating gene products RAG-1 and RAG-2, and only some of the rearrangement events lead to complete HC or LC proteins. All nonproductive HC or LC rearrangements lead to incomplete BCRs, and the lack of signaling that ensues results in apoptosis. Indeed, B cells in Rag-1– or Rag-2–deficient mice do not progress past the pro-B cell stage.48,129 This cell death process involves the Bcl-2–regulated pathway because over-expression of Bcl-2 and Bcl-xL prevents the deletion of pro-B cells in Rag-deficient mice, unable to produce rearrangement of Ig gene segments.130,131 Like for T cells, signals from IL-7 are necessary for the development of early B- cell progenitors, and B-cell development is arrested at the pro–B-cell stage in mice lacking either IL-739 or its receptor.38 Surprisingly, although Bcl-2 over-expression restores T-lymphocyte numbers similar to those of wildtype mice, it fails to produce the same effect on the B- cell population.40,41 Loss of Bim in IL-7Rα-deficient animals also rescued T cells, but had a much lesser effect on B cells.132,133 The requirement for IL-7 signaling in pre–B-cell survival ceases at the immature B-cell stage, where a signal from the BCR and a second signal from a TNF family ligand called BAFF (or BLys), through one of its receptors, are necessary for further differentiation and maturation of B cells.134,135 BAFF deficiency was found to arrest B-cell maturation at the immature transitional type I stage, whereas transgenic expression of BAFF causes accumulation of immature and mature B cells and autoimmunity.136 Current evidence shows that all known BAFF receptors are expressed on B cells at different levels depending on their maturation and/or activation state.134 BAFF-R is the key receptor that triggers BAFF-mediated survival, as mice deficient in this receptor display a phenotype similar to that of BAFF-null mice.137
Maturational stages beyond the immature B-cell stage and survival of mature B cells require continuous signaling through the BCR, as inducible deletion of Ig genes was shown to cause a rapid disappearance of B cells.138
342 |
´ |
DELPHINE MERINO AND PHILIPPE BOUILLET |
2.3.2. Deletion of autoreactive B cells
Like autoreactive T cells, B cells that express a BCR that recognizes self-antigen must be deleted (negative selection) to prevent autoimmunity. Such B cells may also undergo further receptor editing to reduce the affinity of the BCR for self139 or become anergic.140 Deletion of autoreactive B cells can occur in the bone marrow as well as in the spleen and can happen at several developmental stages, from immature pre-BCR bearing cells to mature B cells in germinal centers.141,142 BCR ligationinduced deletion of autoreactive B lymphocytes in vivo is independent of Fas143,144 and not inhibited by overexpression of FADD-DN or caspase-8 inhibitor CrmA in immature B cells lines.145 However, this process can be inhibited by Bcl-2 or Bcl-xL over-expression.131,140,146 Of all BH3-only proteins, Bim again appears as the best candidate to signal death downstream of BCR engagement. Indeed, mice lacking Bim were shown to develop autoimmunity and express autoantibodies.27 In the antiHEL Ig/HEL model of autoreactive B-cell deletion, loss of Bim protected B cells against BCR-induced ligation, demonstrating its role in the process.147
It is interesting to note that genetic background has a strong influence on the consequences of Bim deficiency. The original Bim-/- mice were generated by a targeted mutation in 129Sv ES cells and backcrossed onto C57BL/6 background. Mice of the few first generations developed fatal autoimmune disease at high frequency, whereas homozygous mice produced after >20 generations of backcross have less severe symptoms.27,64 Similarly, BCR-induced apoptosis was shown to be deficient in mice of the MRL background.145 It would be interesting to identify the genes responsible for these differences, as they may be modulators of the Bcl-2–regulated pathway.
2.3.3. Survival and death of activated B cells
Mature B cells critically depend on the BCR signal as well as on an auxiliary signal from the TNF family member BAFF for their survival.134 Both signals are not independent, because BCR ligation upregulates BAFF receptor (BAFF-R) expression on B cells.148 Although BAFF has three receptors (BAFF-R, TACI, and BCMA), only BAFF-R seems to be the key receptor that signals BAFF-mediated survival, as mice deficient for this receptor display the same phenotype (absence of peripheral B cells) as mice deficient for BAFF.149,150 By contrast, TACI seems to be a negative regulator of B-cell survival, as B-cell numbers are increased in TACI-deficient mice, and these animals eventually develop autoimmune disease.151 Survival
signaling through BAFF and BAFF-R involves the activation of the NF-κB pathway, but the details of the signaling cascade have not been elucidated yet. In any case, BAFF has become a major focus of research since the confirmation of its involvement in rheumatoid arthritis and systemic lupus erythematosus–like autoimmune diseases. Several clinical trials using BAFF-neutralizing agents are currently under way.134
The accumulation of antibody-forming cells (AFCs) and consequently abnormally high serum Ig levels in Bim-deficient mice demonstrated the role of Bim in the termination of B-cell immune responses.27
Because Bcl-2 transgenic mice present an increased number of memory T cells,152 it has been postulated that Bim could be involved in the shaping of the memory compartment. A recent study showed that Bim-deficient mice accumulated large numbers of low-affinity Igexpressing memory B cells, in addition to elevated numbers of AFCs.153 Therefore, Bim does not interfere with the affinity maturation process, but seems to be critical for the removal of low-affinity antibody-bearing memory B cells. However, because Bcl-2 transgenic mice accumulated even more antigen-specific B cells than Bim−/− mice, we cannot exclude that another BH3 only protein, such as Puma, could play a part in memory B-cell homeostasis.
The genetic studies mentioned previously involving deletion or over-expression of members of death receptor or Bcl-2–regulated pathways have highlighted that deregulation of cell death mechanisms in T and B lymphocytes have dramatic consequences, ranging from degenerative disorders to autoimmune pathologies. Excessive cell death due to the absence of survival signals (e.g., IL-7) or the lack of a prosurvival molecule (i.e., Bcl-2 or Mcl-1) can lead to a very fragile, if not completely absent, immune system. By contrast, insufficient cell death due to the absence of a proapoptotic mediator (FasL, Fas, Bim, etc.) can lead to an accumulation of immune cells that should normally die and culminate in a fatal autoimmune disease, such as glomerulonephritis. In the Bcl-2 family, Bcl-2 and Mcl-1 seem to be the most important prosurvival regulators. If we consider the expression of Bcl-2 family members in T and B cells,154 it appears that the role of A1 might have been underestimated so far, probably because the genetic deletion of all three A1 genes at once presents a major challenge. Among the BH3-only proteins, Bim really stands out for its multiple roles in so many critical steps of T- and B-cell maturation. Bim plays a major role as a Bcl-2 inhibitor, as demonstrated by the fact that lack of Bim completely rescued the degenerative diseases caused by the lack of Bcl-2.30 Puma also plays